Woodson W. Smelser, MD
Director, Society for Urologic Oncology Fellowship
Assistant Professor of Surgery
Division of Urologic Surgery
- Phone: 314-362-8200
Specialties
- Urologic Surgical Oncology
- Robotic prostatectomy
- Robotic partial nephrectomy
- Robotic adrenalectomy
- Robotic and open cystectomy
- Robotic nephroureterectomy
- Laparoscopic and open nephrectomy
- Orchiectomy
- Ureteroscopy and laser tumor ablation
- Transurethral resection bladder tumor
- Cystoscopy
- Prostate biopsy
- Prostate cancer
- Kidney cancer
- Bladder cancer
- Testicular cancer
- Adrenal cancer
- Elevated Prostate Specific Antigen (PSA)
- Hematuria
Call for patient appointments: 314-362-8200
Meet Dr. Smelser
Dr. Woodson Smelser is a urologic surgeon specializing in comprehensive minimally invasive urologic surgical care.
He has expertise in robotic prostatectomy, adrenalectomy, nephrectomy, and treating urologic cancers.
Dr. Smelser earned his medical degree from University of Missouri. He completed general surgery internship training and urologic surgery residency training at University of Missouri- Kansas City and a urologic oncology fellowship at Vanderbilt University Medical Center.
Degrees
Medical Degree
University of Missouri, Columbia, MO
2015
Residency
General Surgery Internship
University of Missouri-Kansas City, Kansas City, MO
2016
Urologic Surgery Residency
University of Missouri-Kansas City, Kansas City, MO
2020
Fellowship
Post-Doctoral Fellowship, Urologic Oncology
Vanderbilt University Medical Center
2022
Research interests
Prostate cancer
Bladder cancer
Upper tract cancer
Kidney cancer
Testis cancer
Penile cancer
Multidisciplinary cancer management
Locations
Center for Advanced Medicine
Urologic Surgery Center
4921 Parkview Place
St. Louis, MO 63110
Suite: 11C
Fax: 888-425-8245
Appointments: 314-362-8200
Gary C. Werths Building at Siteman Cancer Center
4500 Forest Park Avenue
St. Louis, MO 63108
Floor: 5th
Fax: 888-425-8245
Appointments: 314-362-8200
Hospital affiliations
Barnes-Jewish Hospital
Barnes-Jewish West County Hospital
Missouri Baptist Medical Center
Progress West Hospital
Board certifications
- Urology
Dr. Smelser in the news
- Smelser Receives Young Urologist of the Year Award
- Urologic Surgery Residency and Fellowship Graduation 2023
- Department of Surgery New Faculty: July 2022
Professional Memberships
American Urological Association
Society of Urologic Oncology
American College of Surgeons
South Central Section of the American Urological Association
Awards and Honors
American College of Surgeons Advisory Council Liaison to Urology 2016-2022
American Urological Association Residents and Fellows Committee 2016-2022
American Urological Association Letter of Commendation for Service 2021
Chief Resident in Urology, University of Kansas Medical Center 2020
Best Poster: Bladder Cancer Epidemiology, AUA Meeting 2019
KU Urology Resident Research Award 2018
KU Student Voice, Excellence in Residency Award 2018
Best Poster: Bladder Cancer IV, American Urological Association Meeting 2017
ACS Leadership and Advocacy Summit Scholarship Recipient 2016
Clinical Trials
Perioperative Hypogonadism in Men Undergoing Radical Cystoprostatectomy for Bladder Cancer. NCT0306312. Trial Site: University of Kansas Medical Center. Accrual completed May 2018. Principal Investigators: Woodson Smelser, MD and Jeffrey Holzbeierlein, MD. Manuscript published to Urologic Oncology: Seminars and Investigations, Jan 1, 2021.
Association of Preoperative Medical Optimization with Postoperative Outcomes for High-Risk Patients Undergoing Colorectal Surgery Surgery. Trial Site: Vanderbilt University Medical Center. Departments of Anesthesia, Surgery, and Urology. Principal Investigator: Matt McEvoy. Sub-Investigators: Woodson Smelser, MD, Kamran Idrees, MD, Alexander Hawkins, MD. (Target Opening of August 2022)
Phase II Clinical Trial of Pembrolizumab in Localized Upper Tract Urothelial Carcinoma. Sponsoring Trial Site: Washington University in St. Louis. Principal Investigators: Woodson Smelser, MD and Sam Chang, MD, MBA. Sponsored by Merck Investigator Studies Program. (Target Opening of December 2022)